Louisiana Clinical and Translational Science Center Supplement - COVID Sequence Surveillance Network

路易斯安那州临床和转化科学中心增刊 - COVID 序列监测网络

• 批准号: 10657250
• 负责人: JOHN P. KIRWAN
• 金额: $ 12.4万
• 依托单位: LSU PENNINGTON BIOMEDICAL RESEARCH CTR
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-08-15 至 2027-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10657250
• 关键词: Academic Medical Centers; Biomedical Research; Biostatistics Core; COVID-19 surveillance; Center for Translational Science Activities; Clinical; Clinical Research; Clinical Sciences; Collaborations; Communities; Community Outreach; Development; Epidemiology; Ethics; Evaluation; Funding; Health; Health Sciences; Healthcare Systems; Infrastructure; Institution; Knowledge; Lead; Louisiana; Mission; National Institute of General Medical Sciences; Pediatric Hospitals; Pilot Projects; Preparation; Research; Research Personnel; Resources; School Dentistry; Services; Translational Research; Universities; Veterans; base; biomedical informatics; cohesion; community engagement; coronavirus disease; cyber infrastructure; design; health literacy; improved; programs; surveillance network; working group

PROJECT SUMMARY The Louisiana Clinical and Translational Science (LA CaTS) Center is a consortium of the major academic and biomedical research centers in the State of Louisiana. Pennington Biomedical Research Center (PBRC) is the lead LA CaTS institution and will continue to partner with Louisiana State University Health Sciences Center-New Orleans (LSUHSC-NO) and Tulane University Health Sciences Center (TUHSC) in this effort. LA CaTS Research Partners actively participating during the prior cycle included LSU A&M (Baton Rouge), LSUHSC-Shreveport, Xavier University and Children's Hospital (New Orleans). The overarching objective of the LA CaTS Center for the initial funding cycle was to transform the clinical and translational research efforts of our region away from the status quo, where institutions operated in isolation to pursue their institutional missions, and toward a cohesive, mutually supportive enterprise for clinical and translational research. The LA CaTS Center achieved its objective by developing, implementing and growing a single clinical translational science program for Louisiana based on the development of synergistic programs and unparalleled collaboration from all the major academic and biomedical research institutions in the state We will greatly expand our reach in preparation for the next funding cycle by adding strengths, diversity and resources for clinical and translational research at Southeast Louisiana Veterans Healthcare System (SLVHCS), a newly opened University Medical Center in New Orleans, Ochsner Health and the LSUHSC-NO School of Dentistry. The Specific Aims for the second funding cycle are focused on expansion, enhancement and even greater added value to clinical and translational research in our state. The Specific Aims are as follows: 1) Expand and enhance the existing collaborative infrastructure; 2) Provide additional and coordinated services for successful completion of clinical and translational research both within and across participating institutions; 3) Increase the critical mass of investigators performing clinical and translational research; and 4) Enhance and grow bi-directional relationships with our communities. To achieve these aims, the LA CaTS Center identifies 10 Key Component Activities: Pilot Projects Program; Professional Development Core; Design, Epidemiology and Biostatistics Core; Tracking and Evaluation Core; Clinical Research Resources; Community Engagement and Outreach Resource; Biomedical Informatics Core; Ethics and Regulatory Knowledge Core; Health Literacy Core; and Cyberinfrastructure Enhancement Core.

项目摘要 路易斯安那州临床和转化科学中心（LA CaTS）是一个由主要学术机构组成的联盟。 以及路易斯安那州的生物医学研究中心彭宁顿生物医学研究中心（PBRC）是 领导洛杉矶CaTS机构，并将继续与路易斯安那州州立大学健康科学合作 新奥尔良中心（LSUHSC-NO）和杜兰大学健康科学中心（TUHSC）在这方面的努力。LA CaTS研究合作伙伴积极参与前一个周期包括路易斯安那州立大学A&M（巴吞鲁日）， LSUHSC什里夫波特，泽维尔大学和儿童医院（新奥尔良）。的总体目标 洛杉矶CaTS中心的最初资助周期是改变临床和转化研究工作， 我们的区域摆脱了现状，即各机构孤立地运作， 使命，并朝着一个有凝聚力的，相互支持的企业临床和转化研究。洛杉矶 CaTS中心通过开发、实施和发展单一的临床翻译， 路易斯安那州的科学计划的基础上发展的协同方案和无与伦比的 来自该州所有主要学术和生物医学研究机构的合作 我们将通过增加优势、多样性和 东南路易斯安那退伍军人医疗保健系统的临床和转化研究资源 （SLVHCS），新奥尔良新开设的大学医疗中心，Ochsner Health和LSUHSC-NO 牙科学院。第二个供资周期的具体目标侧重于扩大、加强 为我们州的临床和转化研究带来更大的附加值。具体目标为 1）扩大和加强现有的协作基础设施; 2）提供额外的和协调的 在参与者内部和参与者之间成功完成临床和转化研究的服务 机构; 3）增加进行临床和转化研究的研究人员的临界质量;以及4） 加强和发展与我们社区的双向关系。为了实现这些目标， 中心确定了10个关键组成部分活动：试点项目计划;专业发展核心; 设计、流行病学和生物统计学核心;跟踪和评价核心;临床研究资源; 社区参与和外展资源;生物医学信息学核心;伦理和监管 知识核心;健康素养核心;网络基础设施增强核心。